On February 19, 2019, Judge Winifred Y. Smith issued an order denying Monsanto’s motion to reverse bifurcate the trial in Pilliod v. Monsanto Company, a case that is pending in the Superior Court of the State of California for the County of Alameda. Previously, the MDL judge in the U.S. District Court for the Northern […]
On February 18, 2019, Judge Vince Chhabria in the federal MDL in District Court for the Northern District of California issued an order detailing the admissibility of certain testimony and evidence in the reverse bifurcated MDL proceedings. Read the Court’s order here.
On January 30, 2019, Judge Vince Chhabria in the federal MDL in District Court for the Northern District of California issued an order detailing the admissibility of certain evidence during the causation phase of the upcoming Hardeman v. Monsanto trial. Read the Court’s order here. Read Bayer’s statement here.
On January 18, 2019, Monsanto filed a motion to reverse bifurcate the trial in Pilliod v. Monsanto Company, a case that is pending in the Superior Court of the State of California for the County of Alameda before Judge Winifred Y. Smith. This motion follows an earlier ruling in the MDL in the U.S. District […]
On January 4, 2019, Monsanto filed a motion for summary judgment and specific causation Daubert motions in the Hardeman, Stevick and Gebeyehou v. Monsanto Co. cases, each of which is pending in the MDL in the U.S. District Court for the Northern District of California before Judge Vince Chhabria. Monsanto argues in its brief that […]
On January 3, 2019, Judge Vince Chhabria issued an order to reverse bifurcate the Hardeman, Stevick and Gebeyehou v. Monsanto Co. cases, each of which is pending in the MDL in the U.S. District Court for the Northern District of California. Under reverse bifurcation, the jury will first determine if Roundup® caused the plaintiff’s cancer. If Monsanto prevails, the trial is over. If the jury finds in favor of the plaintiffs in phase […]
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.